Genomic studies demonstrate that, although the majority of the mammalian genome is transcribed, only about 2% of these transcripts are code for proteins. We investigated how the long, polyadenylated Evf2 noncoding RNA regulates transcription of the homeodomain transcription factors DLX5 and DLX6 in the developing mouse forebrain. We found that, in developing ventral forebrain, Evf2 recruited DLX and MECP2 transcription factors to important DNA regulatory elements in the Dlx5/6 intergenic region and controlled Dlx5, Dlx6 and Gad1 expression through trans and cis-acting mechanisms. Evf2 mouse mutants had reduced numbers of GABAergic interneurons in early postnatal hippocampus and dentate gyrus. Although the numbers of GABAergic interneurons and Gad1 RNA levels returned to normal in Evf2 mutant adult hippocampus, reduced synaptic inhibition occurred. These results suggest that noncoding RNA-dependent balanced gene regulation in embryonic brain is critical for proper formation of GABA-dependent neuronal circuitry in adult brain.
The potential of the genome to code for functional noncoding RNAs (ncRNAs) is only beginning to be uncovered 1, 2 . Although many ncRNAs belong to classes of small regulatory RNAs, one subset, long, polyadenylated ncRNAs (lpncRNAs), act cooperatively with protein partners 3 . We previously found that Evf2, a lpncRNA target of sonic hedgehog (SHH) signaling in the developing telencephalon, exhibits trans-acting transcriptional cooperativity with DLX homeodomain proteins, increasing Dlx5/6 enhancer activity in a neural stem cell line 4 . Identification of an ultraconserved Dlx5/6 intergenic DNA regulatory element 5 has led to the discovery of more than 1,000 ultraconserved DNA sequences near important developmental regulators or transcription factors [6] [7] [8] . The domain of Evf2 that is necessary and sufficient for its transcriptionregulating activity lies in this ultraconserved sequence at the 5¢ end of Evf2 RNA 4 . The finding that Evf2 has transcription-regulating activity 4 raised the possibility that subsets of ultraconserved DNA sequences are transcribed and functional. Recently, additional ultraconserved brain lpncRNAs have been identified 9 , supporting the possibility that ultraconserved ncRNAs constitute a new class of transcription-regulating ultraconserved ncRNAs (trucRNAs). In this study, we found, to the best of our knowledge, for first time that the Evf2 trucRNA is important for gene regulation and the development of interneurons that produce GABA, the major inhibitory neurotransmitter in the brain.
The balance between excitation and inhibition in the brain is critical for proper function and is maintained by two major classes of neurons: excitatory projection neurons and inhibitory local circuit interneurons. Although excitation is primarily mediated by the neurotransmitter glutamate, GABA primarily mediates inhibition. Recently, multiple regulatory roles of GABAergic interneurons have been identified 10 . The dysfunction of GABA-regulated circuits has been implicated in different psychiatric disorders, such as schizophrenia, autism and Tourette's syndrome, as well as epilepsy. In methyl CpG-binding protein (Mecp2) mutant mice [11] [12] [13] , a model for the human autism spectrum disorder (ASD) Rett syndrome, GABA-dependent inhibitory cortical activity decreases 14 . In dorsal lateral prefrontal cortex of schizophrenic patients, one of the most consistent findings is a reduction in GAD67, the enzyme responsible for GABA synthesis 15 . Therefore, multiple lines of evidence implicate alterations of GABAergic function in a variety of neurological diseases. Here, we found that a single noncoding RNA controls development of GABAergic interneurons and adult brain circuitry, making this mechanism a target for studying both development and disease.
RESULTS

Trans and cis -gene regulation by Evf2 in vivo
We designed Evf2 loss-of-function mice to determine the role of Evf2 in vivo. Because of the overlap of Evf2 with key Dlx5/6 DNA regulatory elements, we inserted transcription termination sites rather than removing DNA fragments ( Fig. 1a) . We subcloned a 19.4-kb fragment spanning the Dlx5, Dlx6 and Evf genes from a mouse BAC. We then introduced a triple polyadenylation signal 16 into exon 1 (Evf2 TS ; Fig. 1a ). Southern analysis verified correct targeting in embryonic stem (ES) cell lines ( Fig. 1b) and mice (data not shown). Evf2 TS/TS mutant mice were fertile, lived for at least 1 year and were morphologically indistinguishable from wild-type littermate controls (data not shown).
In situ hybridization analysis showed that transcription stop insertion into Evf exon1 eliminated Evf2, but not Evf1 or Dlx5 expression in embryonic day 13.5 (E13.5) ventral telencephalon ( Fig. 1c-h ). Realtime quantitative reverse-transcribed RNA PCR (qRT-PCR) of E13.5 medial ganglionic eminence (MGE) tissue from Evf2 TS/TS mice showed that Dlx6 and 5 transcripts increased by eight and twofold, respectively ( Fig. 1i) . Despite the fact that Evf1 and Dlx5 transcription start sites are approximately equidistant from the triple polyadenylation signal insertion site (Fig. 1a) , Dlx5, but not Evf1, transcription was affected in Evf2 mutants ( Fig. 1i) . Selective transcriptional effects supported the idea that Evf2 loss, rather than insertion of the triple polyadenylation signal sequence, was responsible. If the triple polyadenylation signal insertion was causing the observed transcriptional effects, all Dlx5/6 enhancer activities would be expected to change, including Evf1.
To distinguish between trans and cis-dependent Evf2 RNA regulatory effects, we performed Evf2 electroporation into E12.5 Evf2 TS/TS brains at two different concentrations ( Fig. 1j) . At a lower Evf2 concentration (1 mg) Dlx5 expression decreased, whereas Dlx6 and Evf1 concentrations remain unchanged. At a higher Evf2 concentration (2 mg), the concentrations of both Dlx5 and Dlx6 increased, whereas that of Evf1 did not change. The ability of Evf2 to partially rescue Dlx5 increase suggested that Evf2 trans-regulatory mechanisms were involved in Dlx5 transcriptional control. The inability of ectopically expressed Evf2 to rescue Dlx6 increase in Evf2 TS/TS mutants supported the idea that Evf2 reduced Dlx6 expression through anti-sense competition in cis, rather than by trans, mechanisms. At higher concentrations of Evf2 (2 mg), the concentrations of both Dlx5 and Dlx6 increased, supporting previously published results that Evf2 RNA can function as a transcriptional activator of Dlx5 and Dlx6 ei and eii (conserved intergenic DNA regulatory elements) when ectopically expressed 4 . Electroporation of an Evf2siRNA construct into E12.5 brains also increased the levels of Dlx5 transcripts ( Supplementary Fig. 1 ), further supporting the idea that an Evf2 trans-acting mechanism regulates Dlx5 expression. Together, these data suggested that Evf2-mediated transcriptional control was concentration-dependent, using both trans and cis regulatory mechanisms in vivo.
Evf2 recruitment of DLX and MECP2 to intergenic enhancers
We recently showed that Evf2 forms a complex with DLX proteins in vivo and acts as a transcriptional coactivator of DLX activity with both target and homeodomain specificity in C17 cells 4 . In addition, we proposed a model in which Evf2 recruits DLX proteins to Dlx5/6 intergenic enhancers. Here, however, we found that qRT-PCR analysis of mice lacking Evf2 (Fig. 1i ) indicated that the levels of Dlx5 and Dlx6 transcripts increased, suggesting that Evf2 has a negative, rather than positive, transcription-regulating role in vivo. Rescue experiments ( Fig. 1j) suggested that increased levels of Dlx6 in Evf2 TS/TS mutants resulted from a loss of anti-sense interference in cis, whereas more subtle repressive effects on Dlx5 transcription occurred in trans. To further investigate the mechanism of Evf2-dependent transcriptional control, we used chromatin immunoprecipitation (ChIP) followed by quantitative PCR (ChIP-PCR) on wild-type and Evf2 TS/TS mutant E13.5 MGE chromatin to determine whether Evf2 affects DLX binding to Dlx5 and Dlx6 ei and/or eii. Qualitative ChIP assays using antibodies to DLX1 and 2 previously identified Dlx5/6 ei and eii as specific binding sites ( Fig. 2a) 17 . In wild-type E13.5 MGE, pan-antibodies to DLX proteins 4,18-21 recognized DLX protein-Dlx 5/6 enhancer (ei and eii) complexes (Fig. 2b) . In Evf2 TS/TS mutant chromatin, DLX did not bind to ei and eii ( Fig. 2b) recruitment to Dlx5/6 ei and eii would be expected to decrease Dlx5/6 transcription. However, the number of Dlx5/6 transcripts increased and Dlx2 expression did not change (Fig. 1i) . The report that a twofold increase in Dlx5 can occur in the adult prefrontal cortex on loss of the transcriptional repressor Mecp2 (ref. 23 ) led us to investigate whether loss of Evf2 in the embryonic brain can affect MECP2 binding in the Dlx5/6 region. In the absence of Evf2, MECP2 (ref. 11), a DNA methylbinding protein associated with repressed chromatin, did not bind ei or eii ( Fig. 2c ). One mechanism that was proposed for MECP2-mediated transcriptional repression is its ability to recruit HDAC, a histone deacetylase responsible for chromatin inactivation 24 . However, loss of MECP2 binding to ei in Evf2 mutants did not alter HDAC binding to ei ( Fig. 2d ), suggesting that MECP2 binding functions through an alternate mechanism at this site and stage of development. Loss of MECP2 binding at eii did reduce HDAC binding, suggesting that ei and eii differ in how MECP2 function affects transcriptional regulatory activity by these sites. Although site 2 was previously defined as an MECP2-and HDAC-binding site in the adult prefrontal cortex 23 , MECP2 bound minimally to site 2 at this time during development.
In addition, HDAC bound to site 2 in wild-type embryonic MGE, but reduction of HDAC binding to site 2 in Evf2 TS/TS mutants was not statistically significant (P = 0.5; Fig. 2d ). Therefore, increased Dlx5 expression in Evf2 mutants may result from a loss of MECP2 binding to ei and eii and subsequent loss of HDAC from eii. Evf2 recruited DLX and MECP2 to ei and eii, affecting Dlx5/6 enhancer activities in trans on specific nearby genes, such as Dlx5 but not Evf1, and regulating Dlx6 transcription through anti-sense inhibition in cis (Figs. 1 and 2). Several possibilities may explain how Dlx5, Dlx6 and Evf1 are transcribed in the absence of DLX binding to ei and eii. First, DLX1/2 may only be required for initial activation of Dlx5/6 expression in an Evf2-independent manner; subsequent regulation of Dlx5/6 levels by DLX and MECP2 may then require Evf2. Second, other DLX-binding sites may compensate in the absence of DLX ei/eii interactions. Third, the major role of DLX1 and 2 may be to prevent MECP2 from binding ei/eii, acting through inhibition rather than as direct activators.
Evf2 did not control DLX or MECP2 nuclear localization The absence of DLX and MECP2 protein binding to ei and eii in Evf2 TS/TS mice raised the possibility that Evf2 influences protein stability and/or nuclear localization. In a direct test of the effect of Evf2 on DLX2 protein stability in C17 neural cells, DLX2 protein levels resulting from co-transfection with Evf2 did not change ( Fig. 3a ). In addition, DLX2 protein levels in Evf2 TS/TS mutant embryonic ganglionic eminences did not change compared with those of wild type ( Fig. 3b ). DLX protein distribution in wild type ( Fig. 3c-e ) was indistinguishable from that in Evf2 mutant nuclei ( Fig. 3f-h ). In addition, transcript levels of neuropilin 2 (Nrp2), a direct target of DLX1/2 (ref. 25) , did not change in Evf2 TS/TS mutants ( Fig. 1i ). If Evf2 were controlling DLX protein stability, all DLX1/2 activities would be ) and Evf2 TS/TS mutants (gray bars) using primers 1-6 across the Dlx5/6 region and pan-antibody to DLX (primers 3 and 5, P = 0.025; b), antibody to MECP2 (primers 2, 3 and 5, P = 0.025; c) or antibody to HDAC1 (primers 5 and 6, P = 0.025; d). qChIP-PCR was performed on optimized primer sets using previously defined primer sets (1 ¼ 15, 2 ¼ 24, 4 ¼ 27) 23 and newly defined sets for ei (3, red) , eii (5, red) and external primer (6) . Primer 2 (green) was identified as a MECP2/ HDAC-binding site for transcriptional repression in adult cortex 23 . Error bars represent s.e.m. * P o 0.05, Mann Whitney U test. The schematic in a is reversed from that shown for Evf2 transcription-stop insertion ( Fig. 1) to align with previously published primers 23 . affected, including Nrp2, which is not. These data support a mechanism in which Evf2 recruits DLX to ei and eii, rather than stabilizing DLX protein or directing DLX nuclear localization. We next asked whether the loss of MECP2 binding to ei/eii in Evf2 mutants resulted from its effects on nuclear localization. Analysis of MECP2 localization in developing brain shows a gradient of increasing expression in neurons as they mature, with very little expression in immature neurons 26 . However, expression in E13.5 MGE has not been reported. Analysis of MECP2 in E13.5 MGE nuclei in which Evf2 and DLX are normally expressed showed nonhomogeneous, speckled MECP2 localization (Fig. 3i) . In Evf2 TS/TS mutants, MECP2 distribution is indistinguishable from that in wild type ( Fig. 3i,j) , indicating that failure of MECP2 recruitment to ei and eii in Evf2 mutants did not result from altered subcellular localization.
Reduced numbers of Evf2 TS/TS hippocampal interneurons
The DLX homeodomain protein family is related to the Drosophila Distal-less gene (Dll) 27 . Mice lacking Dlx1 and 2 have a substantial loss of GABAergic interneurons in cortex (B75%) and hippocampus (B90%) as a result of defective migration from embryonic MGE [28] [29] [30] . Loss of Evf2 affected Dlx5/6 expression and DLX function (Figs. 1 and 2) in E13.5 MGE, the source of the majority of GABAergic interneuron precursors that will migrate to the hippocampus and dentate gyrus 29, 31 . We therefore asked whether GABAergic interneuron development in P2 hippocampus or dentate gyrus was affected in mice lacking Evf2.
Expression of Evf2 in developing ventral telencephalon/subventricular zone persisted until birth in P2 subventricular zone and cells that appeared to be migrating to the hippocampus (Fig. 4a ). However, Evf2 was undetectable in wild-type postnatal day 2 (P2) hippocampus and dentate gyrus, as well as in adult subventricular zone or hippocampus (data not shown). In situ hybridization using a probe against Gad1, an enzyme necessary for converting glutamate to GABA, showed that the number of GABAergic interneurons in Evf2 mutant dentate gyrus and hippocampal CA1 and CA3 layers were reduced by 40-65% ( Fig. 4b-d ). Reduced Gad1 (the mouse gene coding for Gad1) expression in Evf2 mutants was accompanied by a reduction in GABA, as shown by GABA immunohistochemistry (Fig. 4e,f) . In situ hybridization against vesicular glutamate transporter 1 (vGlut1, also known as Slc17a7), a gene expressed specifically in glutamatergic neurons showed that vGlut1 expression in Evf2 TS/TS and wild-type hippocampus were similar ( Fig. 4g,h ). In addition, TUNEL staining of Evf2 TS/TS and wild-type hippocampus and dentate gyrus showed similar levels of cell death ( Fig. 4i-k) . Together, these data indicate that Evf2 was required for proper GABAergic interneuron development and that fate transformation or increased cell death were not responsible for this reduction.
Evf2 regulated Gad1 in embryonic, but not adult brain To further understand the role of Evf2 in GABAergic interneuron development, we analyzed Gad1 RNA levels in E13.5 MGE, where GABAergic interneuron precursors first arise. The level of Gad1 transcripts decreased by B30% in Evf2 TS/TS compared with wild-type E13.5 MGE (Fig. 5a ). Electroporation of Evf2 into Evf2 TS/TS E12.5 MGE restored Gad1 levels by B30% compared with a pcDNA control (Fig. 5b) . The ability of Evf2 to rescue decreased Gad1 levels in Evf2 TS/TS mutants, suggesting that Evf2 activates Gad1 transcription through trans-acting mechanisms.
In the forebrain, Evf2 expression was limited to embryonic and early postnatal times of development ( Figs. 1c and 4a) and was undetectable in adult subventricular zone or hippocampus (data not shown). We next asked whether reduced embryonic expression of Gad1 and reduction of GABAergic interneurons seen in early postnatal hippocampus persisted into adulthood. At P60, Evf2 TS/TS Gad1 transcript levels were comparable with those in wild type (Fig. 5c ). In addition, the number of GABAergic interneurons in 8-month-old Evf2 TS/TS and wild-type hippocampus and dentate gyrus were similar (Fig. 5d ). This suggests that Gad1 expression and GABAergic interneuron number in Evf2 mutants recovered to normal levels sometime between early postnatal and 2-month-old hippocampal development, temporally correlating with the timing of Evf2 downregulation.
Reduced synaptic inhibition in Evf2 TS/TS pyramidal neurons Dlx1 À/À mice show a loss of a specific population of hippocampal GABAergic interneurons, which subsequently results in reduced synaptic inhibition 32 . Analysis of Evf2 TS/TS hippocampus not only showed a greater percentage loss of total GABAergic interneurons in early postnatal hippocampus (Fig. 4b) than Dlx1 À/À mice 32 , but also showed that GABAergic defects appeared earlier. In addition, unlike Dlx1 À/À mice, Evf2 TS/TS mice showed recovery of GABAergic interneurons in older animals (Fig. 5c,d) . This led us to ask whether lower levels of embryonic and perinatal Gad1 can cause long-lasting effects on adult synaptic activity, despite apparent transcriptional recovery.
To answer this question, we compared inhibitory postsynaptic currents (IPSCs) in CA1 pyramidal cells from Evf2 TS/TS and wildtype littermates at ages older than P60, when Gad1 mRNA levels have recovered to normal levels. First, we analyzed spontaneous inhibitory postsynaptic currents (sIPSCs) and minimal inhibitory postsynaptic currents (mIPSCs). To maximize outward inhibitory current in artificial cerebrospinal fluid (ACSF) containing glutamate receptor antagonists (20 mM 6-ciano-7-dinitroquinoxaline-2,3-dione (CNQX) and 50 mM D(-)-2-amino-5-phosphonovaleric acid (D-AP5)), we recorded at +20 mV. We added tetrodotoxin (2 mM) to isolate mIPSCs (Fig. 6a,b) . We divided all mice into two age groups: adult (3-5 months old) and old (o12 months old) mice. The two age groups allowed us to distinguish any persistent differences between mutant and wild-type mice from those that might be attributable to specific developmental stages.
Both Evf2 TS/TS age groups showed a significant reduction in sIPSCs event frequency in CA1 pyramidal cells (adult, P = 0.018; old, P = 0.022). sIPSC mean frequency in the adult group was lower in mutant mice by 42% compared with those in wild-type mice. In old mice, sIPSCs event frequency in mutant mice was lower by 38% than in wild types. We observed similar significant reductions in mIPSCs event frequencies in adult and old Evf2 TS/TS groups compared with wild types (adult, P = 0.024; old, P = 0.039). Cumulative probability plots and corresponding Kolmogorov-Smirnov statistical analysis further confirmed the reduction in IPSC frequency in Evf2 TS/TS mice (Fig. 6c,d) . In contrast, we did not find significant differences in sIPSP amplitude or mIPSP amplitude between wild-type and mutant mice (sIPSC: adult (P = 0.217), old (P = 0.417); mIPSC: adult (P = 0.675), old (P = 0.373); Fig. 6e,f) . This suggested that Evf2 did not control the properties of synaptic contacts or GABA receptors formed by normally differentiated interneurons, but instead reduced the number of GABAergic synapses that formed on CA1 pyramidal neurons.
Notably, the frequency of sIPSCs and mIPSCs were lower in old mice than in adult mice, but the comparable age-dependent changes occurred in both Evf2 TS/TS and wild-type mice. Thus, the difference between mutant and wild-type mice persisted. Likewise, the amplitude of sIPSCs increased in old mice. These age differences are consistent with those reported previously 33, 34 .
To further determine whether inhibitory input in CA1 pyramidal neurons were altered in the mutants, we measured the evoked IPSCs in CA1 pyramidal neurons from the adult mice group on stimulation of the stratum radiatum. First, we recorded evoked excitatory postsynaptic currents (EPSCs) with amplitude 0.4-0.2 nA at À70mV, adjusting the stimulus intensity as necessary. Glutamatergic antagonists blocked EPSCs (see above), and a series of evoked IPSCs were recorded at different holding potentials (À70 mV to +20 mV). The I-V plot constructed from these recordings was normalized to the amplitude of evoked EPSCs at À70mV (Fig. 6g) . We included only cells with similar biophysical characteristics in the analysis (wild type, n ¼ 5; mutant, n ¼ 4). Evoked IPSCs were significantly smaller in mutant mice (P o 0.01, paired t test), further suggesting that CA1 pyramidal neurons received less GABAergic innervation.
Finally, we did not find significant changes in the rise or decay times for spontaneous and evoked IPSCs (sIPSCs rise time, P = 0.363; mIPSCs decay time, P = 0.921; evoked IPSCs rise time, P = 0.594; evoked IPSCs decay time, P = 0.240). When added in the recording ACSF, 0.25 mM picrotoxin abolished both spontaneous and evoked IPSCs in all our recordings, confirming the evolvement of GABA A receptors. Therefore, GABAergic interneuron recovery in older mice did not result in the recovery of normal synaptic inhibition in the hippocampus. 
DISCUSSION Noncoding RNA-dependent balanced gene regulation
Our results indicate that the Evf2 noncoding RNA is required for balanced gene regulation in developing ventral forebrain. In Evf2 TS/TS mutants, Dlx6 transcripts increased by about eightfold. The inability to rescue increased Dlx6 in Evf2 TS/TS mutants supports the idea that Evf2 anti-sense transcriptional inhibition of Dlx6 occurs in cis through opposite-strand transcription rather than anti-sense annealing. Data showing that higher Evf2 levels caused an increase rather than a decrease in Dlx6 (Fig. 1j ) support opposite-strand transcriptional inhibition, as would be expected with an anti-sense annealing mechanism. Although we cannot rule out that the triple polyadenylation signal insertion, rather than the loss of Evf2 anti-sense interference, resulted in an increase in Dlx6 transcription, it is unlikely that the triple polyadenylation signal insertion disrupted Dlx5/6 ei or eii, given that Evf1 transcription remained unaffected in Evf2 TS/TS mutants. Furthermore, the triple polyadenylation signal insertion in the 5¢ end of the Air noncoding RNA 35 does not affect adjacent transcription. Together, these data suggest that in vivo Evf2 transcription, rather than Evf2 RNA, negatively regulated Dlx6 transcription through competitive anti-sense inhibition in cis.
In contrast with its effects on Dlx6, the ability of Evf2 to rescue increased Dlx5 and decreased Gad1 indicated that Evf2 RNA negatively regulated Dlx5 and positively regulated Gad1 in trans. Therefore, Evf2-mediated trans-acting transcription-regulating effects were target and concentration dependent; low levels of Evf2 repressed Dlx5 and higher levels activated Dlx5, Dlx6 and Gad1. These results also support previous data that identified trans-acting transcriptional activation of Dlx5/6 ei and eii by Evf2 (ref. 4). Further support for the idea that Evf2 acts in trans to repress Dlx5 stems from our knockdown studies ( Supplementary Fig. 1) .
Studies have shown that SHH activates Dlx and Evf genes and an embryonic form of Gad1 in embryonic forebrain 4, 19 . In addition, ectopic expression of Dlx2 and Dlx5 activates Gad1 in embryonic forebrain slices 36 . Together, these data identify Evf2 and DLX as components of a signaling cascade that activates Gad1, supporting the idea that reduced Gad1 levels in Evf2 TS/TS mutants may result from interference with Evf2/DLX regulation of Gad1. However, both our results and previous results do not distinguish whether the loss of Evf2 directly or indirectly affects Gad1 transcription. Of the two known direct targets of DLX1/2 signaling, Evf2 loss affected Dlx5/6 (ref. 5), but not Nrp2 (ref. 25) (Fig. 1i) , indicating that Evf2 did not affect all Dlx1/2 activities. Therefore, it is possible that unidentified targets of Evf2 may be responsible for Gad1 regulation. An important question raised by these experiments is whether Evf2/DLX directly or indirectly regulates Gad1 expression.
Transcription factor recruitment by noncoding RNAs
Our results indicate that the Evf2 trucRNA is required for positive (DLX) and negative (MECP2) transcription factor recruitment to ultraconserved DNA regulatory elements Dlx5/6 ei and Dlx5/6 eii (Fig. 2) in developing ventral forebrain. The loss of Evf2 prevented the recruitment of a known transcriptional activator (DLX) to positively acting DNA regulatory elements (Dlx5/6 ei and eii), with an unexpected increase, rather than decrease, in Dlx5 transcription. We found that Evf2-mediated recruitment of MECP2, a known transcriptional repressor, was lost from both ei and eii and propose that MECP2 loss may explain Dlx5 deregulation. Despite differences between embryonic and adult MECP2-binding sites in the Dlx5/6 region, Inter-event interval (ms) Inter-event interval (ms) Figure 6 GABAergic synaptic inhibition is reduced in CA1 layer of the adult hippocampus of Evf2 TS/TS mutant mice. (a,b) Representative traces of sIPSCs (1) and mIPSCs (2) a twofold increase in Dlx5 in adult brain occurred on loss of MECP2 (ref. 23 ) and supports a repressive role for MECP2 on Dlx5/6 ei activity. At eii, MECP2 loss was accompanied by HDAC1 loss, suggesting that chromatin in eii was more active in Evf2 mutants, which in turn could increase Dlx5 transcription. However, HDAC1 binding to ei did not change, suggesting that an alternative regulation mechanism was employed at this site. Recent evidence suggests that MECP2 can act as a transcriptional activator in some cases, associating with CREB1 at activated targets 37 . What determines whether MECP2 acts as a transcriptional activator or repressor? Our data indicate that MECP2 recruitment is dependent on Evf2, supporting the possibility that trans-acting RNAs may influence the choice between activator or repressor activities, either through co-recruitment of additional factors or by an unknown mechanism. Another question regarding the mechanism of Evf2-mediated recruitment of MECP2 and DLX proteins is whether recruitment occurs competitively, equally on both alleles or in a mutually exclusive manner ( Supplementary Fig. 2 ). Allelic imbalance causes both subtle (1.5-fold) and marked (ninefold) changes in gene regulation and occurs in 20-50% of tested genes [38] [39] [40] . Similarly, it is possible that the level of Evf2 localized at specific alleles may determine the amount or identity of the factor(s) recruited. Previous fluorescent RNA in situ hybridization data support the idea that E13.5 MGE nuclei have heterogeneous distribution of Evf2 between alleles; in an E13.5 MGE section, Evf2 transcripts may be distributed on single, equal double and unequal double alleles 4 . We found that DLX and MECP2 were also distributed nonhomogenously among different cells and in MGE nuclei (Fig. 3c-j) . These data raise the possibility that unequal distribution of Evf2, DLX and MECP2 may have a role in regulating allelic imbalance in different populations of neuronal precursors, leading to neuronal diversity or phenotypic variation. Further studies to test the possible role of RNA-dependent control of allelic imbalance will be important to understand how cellular diversity arises.
In humans, 15-25% of genes participate in anti-sense transcription 41 ; however, there are only a few reports of an in vivo mechanism that employs specific anti-sense transcriptional regulation 1 . Among these, in vivo roles of anti-sense transcripts have been described for Air 35 and Kcnq1ot1 (ref. 42 ) in imprinting control. The data from our Evf2 mutant analysis, combined with that from our rescue experiments, suggests that Evf2, an anti-sense transcript of Dlx6, negatively regulated Dlx6 transcription in cis through opposite-strand transcriptional competition. However, the ability of Evf2 to regulate Dlx5 and Gad1 in trans raises the possibility that anti-sense transcripts may not be limited to cis-acting mechanisms or even to local regulation. Given the number of known anti-sense transcripts in nonimprinted regions, it will be important to determine how often anti-sense transcripts have trans-regulatory effects and the role of this regulation in various biological processes.
Noncoding RNA-dependent GABAergic interneuron development
The embryonic MGE is regulated by Dlx-dependent mechanisms and produces GABAergic interneuron precursors that will later populate the hippocampus 29 . We found that loss of Evf2 resulted in imbalanced gene expression in the embryonic MGE, leading to decreased GABAergic interneurons in early postnatal (P2) hippocampus and dentate gyrus. Furthermore, this decrease in GABAergic interneurons in P2 Evf2 mutants did not result from increased cell death or a cell-fate transformation in the hippocampus (Fig. 4g-k) .
Why then are GABAergic interneurons decreased in P2 Evf2 mutant hippocampus? One possibility is that decreased Gad1 in E13.5 Evf2 mutant MGE reduced GABA levels in interneuron precursors, altering their tangential ventral to dorsal migration and reducing the number of GABAergic interneurons that reach their destination in the hippocampus. This is supported by reports that GABA affects neuronal migration in multiple contexts 43 , including tangential migration from MGE to cortex 38, 44, 45 . In addition, the interference with DLX1/2 activity that was seen in Evf2 mutants would be expected to impair GABAergic interneuron migration from E13.5 MGE 28, 29 . However, if the majority of GABAergic interneurons derive from embryonic and early postnatal ventral sources that are defective in Evf2 mutants, how then did GABAergic interneuron numbers recover in the adult Evf2 mutant hippocampus? One possibility is that the Evf2 mutant adult compensates by neurogenesis of GABAergic interneurons in either the hippocampal subgranular zone or rostral subventricular zone. If so, it is clear from our electrophysiology experiments that these neurons were not functionally equivalent at the synaptic level to their embryonically generated counterparts. An alternate possibility is that GABAergic precursors in Evf2 mutants migrated at the appropriate time and to the proper destination, but produced lower levels of Gad1 in the absence of Evf2. If migration defects are found, future experiments will be needed to investigate why the numbers of GABAergic interneurons decrease at P2, how they eventually recover and what is the basis for their synaptic defects.
SHH signaling in the embryonic ventral forebrain initiates a transcriptional cascade that requires DLX proteins, Evf2, MECP2 and Gad1 for proper GABAergic interneuron development ( Supplementary  Fig. 3) . Although a large body of literature suggests that the postnatal effects of MECP2 are likely to be critical for Rett syndrome 46, 47 , our results raise the possibility that Evf2 loss and MECP2 loss share a common mechanism, in which transcriptional effects in embryonic MGE cause adult GABAergic defects at the synaptic level. Efforts to identify single or multiple targets of MECP2 in the etiology of Rett syndrome have been inconclusive. Controversial evidence has raised the possibility that deregulation of Dlx5 in adult Mecp2 À/À brains may be responsible for GABAergic defects 23, 48 . However, analysis of Evf2 mutants reveals that the correlation between MECP2 loss, increased Dlx5 and GABAergic defects may be indirect.
Given that DLX5 is a known activator of Gad1 (ref. 36) , GABAergic interneuron loss would not be a predicted effect of the twofold Dlx5 increase in Evf2 mutants. In fact, Evf2 rescue experiments argued against Dlx5 upregulation as a cause for GABAergic defects in Evf2 mutants and suggested that the mechanism involved in Evf2 regulation of Dlx genes is separate from Evf2 regulation of Gad1. Our rescue experiments suggested that Evf2 controls Gad1, Dlx5 and Dlx6 through distinct trans and cis mechanisms. In addition, at the 2 mg Evf2 rescue concentration, Dlx5 increased while Gad1 was rescued. If a twofold Dlx5 increase were the cause of GABAergic defects, Gad1 would not be expected to increase. These experiments suggest that Gad1 reduction, rather than increased Dlx5, is more likely to cause GABAergic interneuron defects.
To the best of our knowledge, these findings describe the first demonstration that an ncRNA-dependent mechanism critical for early GABAergic interneuron development can determine GABAdependent connectivity in the adult brain. The inability to recover proper connectivity, regardless of restored Gad1 and GABAergic interneuron number in adult brain, reinforces the idea that critical factors in the developing embryo influence GABAergic interneuron function in adult. This is especially important given the long-standing question of whether mental disorders, in the absence of apparent physiological adult deficits, can result from altered embryonic development.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
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Primer sequences. For gene targeting, we used the following primers for retrieval homology arms: Cla I (5¢-GAT GCG AAT CGA TCG GCT TAG GCC TCC AGG TTT C-3¢), HindIII (5¢-AAA CCC TAA GCT TGA CTA GCG TGG CCC AAA GGT-3¢), HindIII* (5¢-GAT GCG AAA GCT TCT GTC AGT GCC AAA ATG GAA GGA CAT-3¢), NheI (5¢-GAT GCG AGC TAG CGG GGT TGG GAC CTG GTT TTA GG-3¢). For targeting arms, we used Sac II (5¢-TTA GTT CCG CGG CCT GGT CCT TTC TTC GTC TCA AGT C-3¢), NotI (5¢-ATT TGC GGC CGC CTT AAG AGA TAT TCA CCG GGG TAA GTT TTT ATT-3¢), ClaI (5¢-GAT TTT ATC GAT CAA TGA TCA GGG TCT AGA AAT CTA TAC TGA G-3¢), Kpn (5¢-GAT TTT GGT ACC TTC AGG GTT TGA TTT GAT CGC TAC TG-3¢), 5¢ ES Southern probes mEvf5¢.1 (5¢-TGG TGA AGC TGG AGG AAG GAC-3¢) and mEvf5¢.2 (5¢-CAC ACT GAC TTC TGA ACA CCC CTG-3¢), and 3¢ Southern probes mEvf3¢.1 (5¢-GGG GTG AAG GAT GGT GAT TAA AGA GC-3¢) and mEvf3¢.1 (5¢-GTG GCT GGC TGT CCT TTG GT-3¢).
For quantitative reverse transcription PCR, we used the following primers with SYBR Green: Evf2-F (0. Generation of Evf2 TS/TS mice. The Evf2 targeting construct was generated using lambda phage-based recombineering in E. coli as described previously 49 . Using high-fidelity Taq (Roche), homology arms of approximately 500 bp were PCR amplified (with restriction sites added) from BAC DNA. Using a threefragment ligation, homology arms were cloned into Cla I and Nhe I sites of PL253, with a HindIII site engineered between them. A 16.1-kb region (corresponding to position 6,809,651-6,825,742 on mouse chromosome 6, National Center for Biotechnology Information assembly) was retrieved from pBAC e3.6 M8 (M. Ekker, University of Ottawa) into the retrieval plasmid using recombination-induced EL250 cells 49 . Further targeting was performed on the retrieved plasmid. The polyadenylation targeting vector was constructed in PL452, a floxed-Neo-containing plasmid. The triple polyadenylation signal was cloned into EcoRI and SalI sites of PL452. Approximately 500 bp of targeting homology arms were cloned sequentially on either side of the polyAfloxed-Neo insert. Briefly, fragments were PCR amplified as described above and cloned into either Cla I and KpnI sites or Not I and SacII sites. This triple polyA-floxed-Neo cassette was targeted into the retrieved 16.1-kb region using recombination-induced EL250 cells. Successful targeting was confirmed by Southern blot analysis of the completed construct using internal probes (NEBlot kit, NEB).
Mouse ES cells were targeted by homologous recombination using standard procedures. Successful targeting in ES cells was confirmed by Southern blot, verifying proper recombination at both the 5¢ and 3¢ ends. Probes were generated outside the 16.1-kb homologous region. The 5¢ probe was 499 bp (chromosome 6 bases 6,808,430-6,808,928) and the 3¢ probe was 991 bp (chromosome 6 bases 6,825,821-6,826,811). Wild-type ApaLI sites are at chromosome 6 bases 6,828,765 and 6,817,913, yielding a 10.8-kb fragment that hybridizes with the 3¢ probe. EL250 cells and recombineering plasmids PL253 and PL452 were provided by N. Copeland (National Cancer Institute).
Evf2TS (floxed-Neo) heterozygotes were verified by Southern blot and crossed to EIIAcre mice (Jackson Labs) for two generations. Neo removal was verified by PCR (data not shown). Mice are kept on a mixed 129/FVB/ C57Bl6 background and housed according to guidelines approved by the Institutional Animal Care and Use Committee of the Children's Memorial Research Center.
ChIP. MGE tissue was collected from E13.5 mouse Evf2 +/+ or Evf2 TS/TS embryos (10-15 embryos per group). Tissue was broken into single cells by pipetting and spun through a 70-mm filter. The DNA was crosslinked with 1% paraformaldehyde (wt/vol) for 90 min on a rotator and then resuspended in SDS lysis buffer (1% SDS (wt/vol), 50 mM Tris-HCl (pH 8.1) and 10 mM EDTA) and the protease inhibitors PMSF (170 mg ml À1 ), pepstatin (0.7 mg ml À1 ), leupeptin (10 mg ml À1 ) and aprotinin (10 mg ml À1 ). The crosslinked DNA was sonicated on a Microson Ultrasonic Cell Disruptor at power 6 for six pulses of 10 s each. The sonicated mixture was spun down and the supernatant was used for ChIP.
For each immunoprecipitation condition, 20 mg of chromatin was used in a total volume of 1,000 ml TES buffer (50 mM Tris-HCl (pH 8.1), 1 mM EDTA and 150 mM NaCl) plus protease inhibitors. The chromatin was precleared on a rotator at 4 1C. We added 75 ml of washed Protein G-Agarose beads for 1 h and incubated the supernatant with 10 ml of rabbit pre-immune serum for 1 h. Afterwards, 75 ml of Protein G-Agarose were added for 1 h and the supernatant was split in half for an antibody condition and a rabbit pre-immune condition. The chromatin was immunoprecipitated at 4 1C. Antibody (5 mg) or rabbit prei-mmune serum (2 ml) were added for 4 h and then 100 ml of Protein G-Agarose was added overnight. The Protein G-Agarose beads were washed twice with low salt buffer (0.1% SDS, 1% Triton X-100 (vol/vol), 2 mM EDTA, 20 mM Tris-HCl (pH 9.1) and 150 mM NaCl), once with 500 mM NaCl, twice with LiCl buffer (0.25M LiCl, 1% sodium deoxycholate (wt/vol), 1 mM EDTA, 10 mM Tris-HCl (pH 8.1) and 1% tert-octylphenoxy poly(oxyethylene)ethanol (vol/vol, Sigma)), and twice with TE buffer (10 mM Tris-HCl (pH 8.1) and 1 mM EDTA). The chromatin was then eluted off the Protein G-Agarose beads by incubation with 100 ml of elution buffer (1% SDS, and 0.1 M NaHCO 3 ) twice. The DNA crosslinking was reversed by incubation in 0.5 M NaCl for 5 h at 65 1C. Then the DNA was proteinase K treated by adding half a volume of 15 mM EDTA/30 mM Tris-HCl (pH 8.1) and 750 mg ml À1 proteinase K for 1 h at 65 1C. The uncrosslinked DNA was phenol extracted and ethanol precipitated using glycogen. Rabbit pan-antibody to Dll was produced in the laboratory. Pan-antibodies to Dlx, as originally described 18 , were made in our laboratory and extensively characterized 4 . Pan-antibodies to Dlx were raised in rabbits against the 62 amino acid butterfly Dll homeodomaincontaining fragment, affinity purified and tested by western blot (Dll fragment and zebrafish Dlx1, 2, 4 and 6, and mouse Dlx2) and immunohistochemistry (neural explants, embryonic forebrain sections). Pan-antibody to Dlx recognizes zebrafish Dlx family members, including Dlx1, 2, 4 and 6 (ref. 4).
Monoclonal anti-Mecp2 antibodies were obtained commercially (Affinity Bioreagents) and characterized previously 26 . We verified that these antibodies to Mecp2 bound only two bands in adult olfactory bulb extracts by western analysis (data not shown). Antibodies to HDAC1 were obtained from Sigma. Primers were optimized to concentrations at which they were B100% efficient with a standard curve slope of BÀ3. 32 .
The enrichment of the antibodies and rabbit pre-immune serum were determined by comparing the Ct values (threshold cycle number) of the
